DE2362991A1 - Arzneipraeparate zur direkten einfuehrung in koerperhoehlen - Google Patents
Arzneipraeparate zur direkten einfuehrung in koerperhoehlenInfo
- Publication number
- DE2362991A1 DE2362991A1 DE2362991A DE2362991A DE2362991A1 DE 2362991 A1 DE2362991 A1 DE 2362991A1 DE 2362991 A DE2362991 A DE 2362991A DE 2362991 A DE2362991 A DE 2362991A DE 2362991 A1 DE2362991 A1 DE 2362991A1
- Authority
- DE
- Germany
- Prior art keywords
- spermicide
- contain
- medicinal preparations
- preparations according
- medicinal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims description 33
- 239000000934 spermatocidal agent Substances 0.000 claims description 22
- 229920000642 polymer Polymers 0.000 claims description 18
- 239000003814 drug Substances 0.000 claims description 13
- 229940079593 drug Drugs 0.000 claims description 13
- 239000000835 fiber Substances 0.000 claims description 13
- 239000003433 contraceptive agent Substances 0.000 claims description 8
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims description 5
- 239000004372 Polyvinyl alcohol Substances 0.000 claims description 5
- 210000001124 body fluid Anatomy 0.000 claims description 5
- 239000010839 body fluid Substances 0.000 claims description 5
- 239000001863 hydroxypropyl cellulose Substances 0.000 claims description 5
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 5
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N EtOH Substances CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 4
- 230000003111 delayed effect Effects 0.000 claims description 4
- 239000012907 medicinal substance Substances 0.000 claims description 4
- 150000003431 steroids Chemical class 0.000 claims description 4
- CAFAOQIVXSSFSY-UHFFFAOYSA-N 1-ethoxyethanol Chemical compound CCOC(C)O CAFAOQIVXSSFSY-UHFFFAOYSA-N 0.000 claims description 3
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 claims description 3
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 claims description 2
- 229920002472 Starch Polymers 0.000 claims description 2
- 229920000615 alginic acid Polymers 0.000 claims description 2
- 235000010443 alginic acid Nutrition 0.000 claims description 2
- 229920002678 cellulose Polymers 0.000 claims description 2
- 239000001913 cellulose Substances 0.000 claims description 2
- 235000010980 cellulose Nutrition 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 230000002254 contraceptive effect Effects 0.000 claims description 2
- 229920002401 polyacrylamide Polymers 0.000 claims description 2
- 235000019422 polyvinyl alcohol Nutrition 0.000 claims description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 2
- 150000003180 prostaglandins Chemical class 0.000 claims description 2
- 239000008107 starch Substances 0.000 claims description 2
- 235000019698 starch Nutrition 0.000 claims description 2
- 229920001169 thermoplastic Polymers 0.000 claims description 2
- 239000004416 thermosoftening plastic Substances 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims 1
- 238000000034 method Methods 0.000 description 13
- 238000012986 modification Methods 0.000 description 10
- 230000004048 modification Effects 0.000 description 10
- 229940124558 contraceptive agent Drugs 0.000 description 6
- 239000008188 pellet Substances 0.000 description 6
- 235000009161 Espostoa lanata Nutrition 0.000 description 5
- 240000001624 Espostoa lanata Species 0.000 description 5
- 239000004480 active ingredient Substances 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- 230000000694 effects Effects 0.000 description 4
- 239000013504 Triton X-100 Substances 0.000 description 3
- 229920004890 Triton X-100 Polymers 0.000 description 3
- 230000004888 barrier function Effects 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 238000006266 etherification reaction Methods 0.000 description 3
- 239000002657 fibrous material Substances 0.000 description 3
- 238000009987 spinning Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- FBWNMEQMRUMQSO-UHFFFAOYSA-N tergitol NP-9 Chemical compound CCCCCCCCCC1=CC=C(OCCOCCOCCOCCOCCOCCOCCOCCOCCO)C=C1 FBWNMEQMRUMQSO-UHFFFAOYSA-N 0.000 description 3
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- XXROGKLTLUQVRX-UHFFFAOYSA-N allyl alcohol Chemical compound OCC=C XXROGKLTLUQVRX-UHFFFAOYSA-N 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 238000012377 drug delivery Methods 0.000 description 2
- 238000001125 extrusion Methods 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 2
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 2
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 2
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 2
- 239000011872 intimate mixture Substances 0.000 description 2
- 235000015110 jellies Nutrition 0.000 description 2
- 229940126601 medicinal product Drugs 0.000 description 2
- 238000002074 melt spinning Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000000825 pharmaceutical preparation Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000003825 pressing Methods 0.000 description 2
- WBHHMMIMDMUBKC-XLNAKTSKSA-N ricinelaidic acid Chemical compound CCCCCC[C@@H](O)C\C=C\CCCCCCCC(O)=O WBHHMMIMDMUBKC-XLNAKTSKSA-N 0.000 description 2
- 229960003656 ricinoleic acid Drugs 0.000 description 2
- FEUQNCSVHBHROZ-UHFFFAOYSA-N ricinoleic acid Natural products CCCCCCC(O[Si](C)(C)C)CC=CCCCCCCCC(=O)OC FEUQNCSVHBHROZ-UHFFFAOYSA-N 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 230000001150 spermicidal effect Effects 0.000 description 2
- 230000009885 systemic effect Effects 0.000 description 2
- 210000001215 vagina Anatomy 0.000 description 2
- JCIIKRHCWVHVFF-UHFFFAOYSA-N 1,2,4-thiadiazol-5-amine;hydrochloride Chemical compound Cl.NC1=NC=NS1 JCIIKRHCWVHVFF-UHFFFAOYSA-N 0.000 description 1
- XEFAJZOBODPHBG-UHFFFAOYSA-N 1-phenoxyethanol Chemical class CC(O)OC1=CC=CC=C1 XEFAJZOBODPHBG-UHFFFAOYSA-N 0.000 description 1
- 241000282560 Macaca mulatta Species 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 206010046810 Uterine perforation Diseases 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 238000005266 casting Methods 0.000 description 1
- 235000019994 cava Nutrition 0.000 description 1
- 229920003086 cellulose ether Polymers 0.000 description 1
- 239000000701 coagulant Substances 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 235000019441 ethanol Nutrition 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 150000002730 mercury Chemical class 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 229920000847 nonoxynol Polymers 0.000 description 1
- -1 nonylphenoxy Chemical group 0.000 description 1
- 230000016087 ovulation Effects 0.000 description 1
- 229940094443 oxytocics prostaglandins Drugs 0.000 description 1
- 230000036407 pain Effects 0.000 description 1
- 229940096826 phenylmercuric acetate Drugs 0.000 description 1
- XEBWQGVWTUSTLN-UHFFFAOYSA-M phenylmercury acetate Chemical compound CC(=O)O[Hg]C1=CC=CC=C1 XEBWQGVWTUSTLN-UHFFFAOYSA-M 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000007910 systemic administration Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 238000002166 wet spinning Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Orthopedics, Nursing, And Contraception (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US316175A US3875300A (en) | 1972-12-18 | 1972-12-18 | Composition for sustained release of a medicament and method of using same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE2362991A1 true DE2362991A1 (de) | 1974-06-20 |
Family
ID=23227840
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE2362991A Pending DE2362991A1 (de) | 1972-12-18 | 1973-12-18 | Arzneipraeparate zur direkten einfuehrung in koerperhoehlen |
Country Status (13)
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102020131179A1 (de) | 2020-11-25 | 2022-05-25 | Universität Rostock | Resorbierbare dreidimensionale Hohlfaserstruktur zur Verwendung in Tamponaden und/oder Wundauflagen und Verfahren zur Herstellung einer resorbierbaren dreidimensionalen Hohlfaserstruktur zur Verwendung in Tamponaden und/oder Wundauflagen |
Families Citing this family (77)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4179497A (en) * | 1973-12-17 | 1979-12-18 | Merck & Co., Inc. | Solid state ophthalmic medication |
| DK137946B (da) * | 1973-12-17 | 1978-06-12 | Merck & Co Inc | Bæremedium i fast form til anvendelse i ophthalmiske præparater. |
| US4136145A (en) * | 1974-07-05 | 1979-01-23 | Schering Aktiengesellschaft | Medicament carriers in the form of film having active substance incorporated therein |
| US3982537A (en) * | 1974-12-30 | 1976-09-28 | Louis Bucalo | Dynamic implants and method for implanting the same |
| US3946734A (en) * | 1975-02-19 | 1976-03-30 | The United States Of America As Represented By The Secretary Of State | Apparatus for controlling the release of a drug |
| NL188266C (nl) * | 1975-07-29 | 1992-05-18 | Merck & Co Inc | Werkwijze ter bereiding van een oogheelkundig inplantaat. |
| US4045558A (en) * | 1975-10-08 | 1977-08-30 | Merck & Co., Inc. | Pilocarpine salts |
| US4077407A (en) * | 1975-11-24 | 1978-03-07 | Alza Corporation | Osmotic devices having composite walls |
| GB1593261A (en) * | 1976-07-23 | 1981-07-15 | Inveresk Res Int | Controlled release suppository |
| US4309997A (en) * | 1978-06-09 | 1982-01-12 | Donald Jack W | Contraceptive and/or antivenereal disease tampon |
| US4186742A (en) * | 1978-06-09 | 1980-02-05 | Donald Enterprises, Inc. | Contraceptive-antivenereal disease tampon |
| US4287175A (en) * | 1978-06-22 | 1981-09-01 | Merck & Co., Inc. | Contact lens wetting agents |
| US4732763A (en) * | 1978-10-17 | 1988-03-22 | Stolle Research And Development Corporation | Active/passive immunization of the internal female reproductive organs |
| US4585651A (en) * | 1978-10-17 | 1986-04-29 | Stolle Research & Development Corporation | Active/passive immunization of the internal female reproductive organs |
| CA1143289A (en) * | 1978-10-17 | 1983-03-22 | Lee R. Beck | Microparticle drug delivery system |
| JPS6042766B2 (ja) * | 1978-12-09 | 1985-09-25 | 日本化薬株式会社 | 基剤 |
| SE431821B (sv) * | 1979-01-29 | 1984-03-05 | Perstorp Ab | Lagringsstabilt, prostaglandininnehallande medicinskt preparat |
| JPS5634619A (en) * | 1979-08-31 | 1981-04-06 | Ono Pharmaceut Co Ltd | Production of prostaglandin vaginal suppository |
| US4259314A (en) * | 1979-12-10 | 1981-03-31 | Hans Lowey | Method and composition for the preparation of controlled long-acting pharmaceuticals |
| JPS5832816A (ja) * | 1981-08-20 | 1983-02-25 | Shin Etsu Chem Co Ltd | 避妊用フイルム製剤 |
| JPS58206512A (ja) * | 1982-05-27 | 1983-12-01 | ウイジヤヤ・チヤンドラ | 女性外用避妊膜 |
| US4673565A (en) * | 1985-05-03 | 1987-06-16 | E. I. Du Pont De Nemours And Company | Pharmaceutical compositions containing hollow fine tubular drug delivery systems |
| CA1272922A (en) * | 1986-06-03 | 1990-08-21 | Peter William Berry | Drug delivery device, its preparation and use |
| US4841968A (en) * | 1986-09-26 | 1989-06-27 | Southern Research Institute | Antithrombotic/thrombolytic suture and methods of making and using the same |
| US5456932A (en) * | 1987-04-20 | 1995-10-10 | Fuisz Technologies Ltd. | Method of converting a feedstock to a shearform product and product thereof |
| US5387431A (en) * | 1991-10-25 | 1995-02-07 | Fuisz Technologies Ltd. | Saccharide-based matrix |
| US5422136A (en) * | 1987-04-20 | 1995-06-06 | Fuisz Technologies Ltd. | Starch-based food enhancing ingredient |
| US5236734A (en) * | 1987-04-20 | 1993-08-17 | Fuisz Technologies Ltd. | Method of preparing a proteinaceous food product containing a melt spun oleaginous matrix |
| US4997856A (en) * | 1987-04-20 | 1991-03-05 | Fuisz Pharmaceutical Ltd. | Method of producing compacted dispersable systems |
| US5286513A (en) * | 1987-04-20 | 1994-02-15 | Fuisz Technologies Ltd. | Proteinaceous food product containing a melt spun oleaginous matrix |
| US5238696A (en) * | 1987-04-20 | 1993-08-24 | Fuisz Technologies Ltd. | Method of preparing a frozen comestible |
| US5516537A (en) * | 1987-04-20 | 1996-05-14 | Fuisz Technologies Ltd. | Frozen comestibles |
| US4873085A (en) * | 1987-04-20 | 1989-10-10 | Fuisz Pharmaceutical Ltd. | Spun fibrous cosmetic and method of use |
| US5034421A (en) * | 1988-12-13 | 1991-07-23 | Fuisz Pharmaceutical Ltd. | Moderated spun fibrous system and method of manufacture |
| US4855326A (en) * | 1987-04-20 | 1989-08-08 | Fuisz Pharmaceutical Ltd. | Rapidly dissoluble medicinal dosage unit and method of manufacture |
| US5545615A (en) * | 1987-09-18 | 1996-08-13 | Zymogenetics, Inc. | A method of inhibiting fertilization by alpha-1-antitrypsin or antithrombin III |
| ES2017282A6 (es) * | 1989-07-28 | 1991-01-16 | Aguilera Franco Maria | Aposito para aplicaciones de substancias activas por via transcutanea con fines terapeuticos o cosmeticos. |
| US5380529A (en) * | 1990-07-10 | 1995-01-10 | Laboratoire Lucchini S.A. | Pharmaceutical, vaginal applicable preparation and a process for its preparation |
| US5196199A (en) * | 1990-12-14 | 1993-03-23 | Fuisz Technologies Ltd. | Hydrophilic form of perfluoro compounds and method of manufacture |
| US5268110A (en) * | 1991-05-17 | 1993-12-07 | Fuisz Technologies Ltd. | Oil removing method |
| CA2109622A1 (en) * | 1991-05-17 | 1992-11-26 | Richard C. Fuisz | New thermoplastic polymeric material and process for making same |
| US5576042A (en) * | 1991-10-25 | 1996-11-19 | Fuisz Technologies Ltd. | High intensity particulate polysaccharide based liquids |
| JP3802555B2 (ja) * | 1991-12-17 | 2006-07-26 | フイズ テクノロジーズ リミテッド | 潰瘍予防及び治療組成物並びに方法 |
| US5427804A (en) * | 1992-03-05 | 1995-06-27 | Fuisz Technologies Ltd. | Low-fat edible proteins with maltodextrins and low-saturate oils |
| US5654003A (en) * | 1992-03-05 | 1997-08-05 | Fuisz Technologies Ltd. | Process and apparatus for making tablets and tablets made therefrom |
| CA2095776C (en) * | 1992-05-12 | 2007-07-10 | Richard C. Fuisz | Rapidly dispersable compositions containing polydextrose |
| US5279849A (en) * | 1992-05-12 | 1994-01-18 | Fuisz Technologies Ltd. | Dispersible polydextrose, compositions containing same and method for the preparation thereof |
| US5728397A (en) * | 1992-05-12 | 1998-03-17 | Fuisz Technologies Ltd. | Polydextrose product and process |
| US5518730A (en) * | 1992-06-03 | 1996-05-21 | Fuisz Technologies Ltd. | Biodegradable controlled release flash flow melt-spun delivery system |
| US5348758A (en) * | 1992-10-20 | 1994-09-20 | Fuisz Technologies Ltd. | Controlled melting point matrix formed with admixtures of a shearform matrix material and an oleaginous material |
| US5380473A (en) * | 1992-10-23 | 1995-01-10 | Fuisz Technologies Ltd. | Process for making shearform matrix |
| GR940100370A (el) * | 1993-07-28 | 1994-07-26 | Johnson & Johnson Consumer Products Inc. | Μια σπερμοκτονος λιπαντικη αντι-ιου συνθεση και μεθοδος χρησης της. |
| US5622719A (en) * | 1993-09-10 | 1997-04-22 | Fuisz Technologies Ltd. | Process and apparatus for making rapidly dissolving dosage units and product therefrom |
| US5895664A (en) * | 1993-09-10 | 1999-04-20 | Fuisz Technologies Ltd. | Process for forming quickly dispersing comestible unit and product therefrom |
| US5851553A (en) * | 1993-09-10 | 1998-12-22 | Fuisz Technologies, Ltd. | Process and apparatus for making rapidly dissolving dosage units and product therefrom |
| US5597416A (en) * | 1993-10-07 | 1997-01-28 | Fuisz Technologies Ltd. | Method of making crystalline sugar and products resulting therefrom |
| US5518551A (en) * | 1993-09-10 | 1996-05-21 | Fuisz Technologies Ltd. | Spheroidal crystal sugar and method of making |
| US5346377A (en) * | 1993-10-07 | 1994-09-13 | Fuisz Technologies Ltd. | Apparatus for flash flow processing having feed rate control |
| US6020002A (en) * | 1994-06-14 | 2000-02-01 | Fuisz Technologies Ltd. | Delivery of controlled-release system(s) |
| US5567439A (en) * | 1994-06-14 | 1996-10-22 | Fuisz Technologies Ltd. | Delivery of controlled-release systems(s) |
| US5445769A (en) * | 1994-06-27 | 1995-08-29 | Fuisz Technologies Ltd. | Spinner head for flash flow processing |
| US5582855A (en) * | 1994-07-01 | 1996-12-10 | Fuisz Technologies Ltd. | Flash flow formed solloid delivery systems |
| US5843922A (en) * | 1994-07-29 | 1998-12-01 | Fuisz Technologies Ltd. | Preparation of oligosaccharides and products therefrom |
| US5556652A (en) * | 1994-08-05 | 1996-09-17 | Fuisz Technologies Ltd. | Comestibles containing stabilized highly odorous flavor component delivery systems |
| US5587198A (en) * | 1995-05-31 | 1996-12-24 | Fuisz Technologies Ltd. | Positive hydration method of preparing confectionery and product therefrom |
| US6841574B2 (en) * | 2003-01-03 | 2005-01-11 | Nexmed Holdings, Inc. | Topical stabilized prostaglandin E compound dosage forms |
| US20130136784A1 (en) * | 2007-10-11 | 2013-05-30 | Robert J. Staab | Methods for delivery of medication using dissolvable devices |
| MX2012015174A (es) | 2010-07-02 | 2013-05-09 | Procter & Gamble | Filamentos que comprenden un agente activo, tramas de tela no tejida y métodos para elaborarlos. |
| RU2555042C2 (ru) | 2010-07-02 | 2015-07-10 | Дзе Проктер Энд Гэмбл Компани | Способ доставки активнодействующего вещества |
| CN103003476B (zh) | 2010-07-02 | 2016-02-10 | 宝洁公司 | 纤维网材料以及用于制造纤维网材料的方法 |
| RU2541275C2 (ru) * | 2010-07-02 | 2015-02-10 | Дзе Проктер Энд Гэмбл Компани | Филаменты, содержащие неароматизированный активный агент, нетканые полотна и способы их получения |
| CN110167639B (zh) | 2017-01-27 | 2022-10-14 | 宝洁公司 | 呈包含泡腾型附聚颗粒的可溶性固体结构形式的组合物 |
| WO2018213003A1 (en) | 2017-05-16 | 2018-11-22 | The Procter & Gamble Company | Conditioning hair care compositions in the form of dissolvable solid structures |
| US11666514B2 (en) | 2018-09-21 | 2023-06-06 | The Procter & Gamble Company | Fibrous structures containing polymer matrix particles with perfume ingredients |
| MX2021013141A (es) | 2019-06-28 | 2021-12-10 | Procter & Gamble | Articulos fibrosos solidos disolubles que contienen surfactantes anionicos. |
| JP7506249B2 (ja) | 2020-07-31 | 2024-06-25 | ザ プロクター アンド ギャンブル カンパニー | ヘアケア用プリル含有水溶性繊維パウチ |
| CN114397391B (zh) * | 2022-01-21 | 2023-04-28 | 苏州南医大创新中心 | 一种精液中与无精子症有关的分子标志物蓖麻油酸及其检测方法和应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3067743A (en) * | 1958-11-12 | 1962-12-11 | Alginate Ind Ltd | Alginic compounds |
| US3108043A (en) * | 1960-05-09 | 1963-10-22 | Ortho Pharma Corp | Spermicidal sheet-like material |
-
1972
- 1972-12-18 US US316175A patent/US3875300A/en not_active Expired - Lifetime
-
1973
- 1973-12-10 GB GB5704473A patent/GB1446626A/en not_active Expired
- 1973-12-10 FR FR7344027A patent/FR2210415B1/fr not_active Expired
- 1973-12-11 BE BE138771A patent/BE808519A/xx unknown
- 1973-12-14 ZA ZA00739502A patent/ZA739502B/xx unknown
- 1973-12-17 BR BR9861/73A patent/BR7309861D0/pt unknown
- 1973-12-17 IT IT54360/73A patent/IT1047937B/it active
- 1973-12-17 IL IL43839A patent/IL43839A0/xx unknown
- 1973-12-17 AU AU63720/73A patent/AU6372073A/en not_active Expired
- 1973-12-17 JP JP48139715A patent/JPS49133519A/ja active Pending
- 1973-12-18 DE DE2362991A patent/DE2362991A1/de active Pending
- 1973-12-18 AT AT1060573A patent/AT332532B/de not_active IP Right Cessation
- 1973-12-18 NL NL7317324A patent/NL7317324A/xx unknown
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102020131179A1 (de) | 2020-11-25 | 2022-05-25 | Universität Rostock | Resorbierbare dreidimensionale Hohlfaserstruktur zur Verwendung in Tamponaden und/oder Wundauflagen und Verfahren zur Herstellung einer resorbierbaren dreidimensionalen Hohlfaserstruktur zur Verwendung in Tamponaden und/oder Wundauflagen |
Also Published As
| Publication number | Publication date |
|---|---|
| IT1047937B (it) | 1980-10-20 |
| GB1446626A (en) | 1976-08-18 |
| FR2210415A1 (enrdf_load_stackoverflow) | 1974-07-12 |
| NL7317324A (enrdf_load_stackoverflow) | 1974-06-20 |
| IL43839A0 (en) | 1974-03-14 |
| ATA1060573A (de) | 1976-01-15 |
| BE808519A (fr) | 1974-06-11 |
| ZA739502B (en) | 1975-07-30 |
| FR2210415B1 (enrdf_load_stackoverflow) | 1977-04-15 |
| US3875300A (en) | 1975-04-01 |
| BR7309861D0 (pt) | 1974-09-24 |
| AT332532B (de) | 1976-10-11 |
| JPS49133519A (enrdf_load_stackoverflow) | 1974-12-21 |
| AU6372073A (en) | 1975-06-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2362991A1 (de) | Arzneipraeparate zur direkten einfuehrung in koerperhoehlen | |
| DE69920344T2 (de) | Verwendung eines Acrylsäure-Typ Polymeres als Desintegrationsmittel, Vefahren zur Herstellung von Tabletten und hergestellte Tabletten | |
| DE60112772T2 (de) | Suppositorien die im unteren rectum zurückgehalten werden | |
| DE69429119T2 (de) | Verfahren zur herstellung von gefriergetrockneten arzneistoffdosierungsformen | |
| DE69016755T2 (de) | Pharmazeutische Zubereitung mit verzögerter Freisetzung zur Behandlung periodontaler Erkrankungen. | |
| DE69309701T3 (de) | Zusammensetzungen mit verzögerter wirkstoffabgabe zur behandlung periodontaler erkrankungen | |
| DE2547378C2 (enrdf_load_stackoverflow) | ||
| DE2727913C2 (enrdf_load_stackoverflow) | ||
| DE2525061C2 (de) | Formkörper zur Abgabe eines Wirkstoffs und Verfahren zu dessen Herstellung | |
| DE69732760T2 (de) | Intravaginal-ringe mit einsetzbarem medikamentenenthaltenden kern | |
| AT398165B (de) | Verfahren zur herstellung einer pharmazeutischen kapsel zur oralen verabreichung mit verzögerter wirkstofffreisetzung bzw. kombinierter verzögerter/rascher wirkstofffreisetzung | |
| DE69622980T2 (de) | Bioadhäsives Arzneimittel zur kontrollierten Freisetzung von Wirkstoffen | |
| DE69519235T2 (de) | Hämorrhoidenzusammensetzungen und verfahren zur verwendung | |
| DE2449865A1 (de) | Arzneimittel in folienform mit inkorporiertem wirkstoff | |
| DE2755505A1 (de) | Abgabemittel fuer biologisch aktive stoffe | |
| DE2432925A1 (de) | Arzneimittelwirkstofftraeger in folienform mit inkorporiertem wirkstoff | |
| DE3045634A1 (de) | Pharmazeutisches praeparat mit langsamer wirkstofffreisetzung und verfahren zu dessen herstellung | |
| CH638987A5 (de) | Langsam und gleichmaessig wirkstoffe freisetzende pharmazeutische zubereitung. | |
| DE60216495T2 (de) | Vaginale zusammensetzung enthaltend lidocaine zur behandlung von gebärmutterrhythmusstörung | |
| DE19954245A1 (de) | Mehrschichtige filmförmige Zubereitung aus hydrophilen Polymeren zur schnellen Freisetzung von Wirkstoffen | |
| DE2610880A1 (de) | Artikel fuer kontrollierte wirkstofffreigabe | |
| CH625704A5 (en) | Pharmaceutical composition in sheet form | |
| DE69429964T2 (de) | Feste, therapeutische oder hygienische, mucoadhäsive Zusammensetzung zur Verabreichung durch Auftragen auf der Mund-schleimhaut oder der Nasen-schleimhaut | |
| DE2213604C2 (de) | Vaginalzäpfchen zur Empfängnisverhütung | |
| DE69721314T2 (de) | Hormonzusammensetzung welche ein östrogenes mittel und ein progestatives mittel enthält |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| OHJ | Non-payment of the annual fee |